Publication: Virtual screening against acetylcholine binding protein
Issued Date
2012-02-01
Resource Type
ISSN
1552454X
10870571
10870571
Other identifier(s)
2-s2.0-84856300928
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Biomolecular Screening. Vol.17, No.2 (2012), 204-215
Suggested Citation
Maleeruk Utsintong, Piyanuch Rojsanga, Kwok Yiu Ho, Todd T. Talley, Arthur J. Olson, Kinzo Matsumoto, Opa Vajragupta Virtual screening against acetylcholine binding protein. Journal of Biomolecular Screening. Vol.17, No.2 (2012), 204-215. doi:10.1177/1087057111421667 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/13816
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Virtual screening against acetylcholine binding protein
Abstract
The nicotinic acetylcholine receptors (nAChRs) are a member of the ligand-gated ion channel family and play a key role in the transfer of information across neurological networks. The X-ray crystal structure of agonist-bound α7 acetylcholine binding protein (AChBP) has been recognized as the most appropriate template to model the ligand-binding domain of nAChR for studying the molecular mechanism of the receptor-ligand interactions. Virtual screening of the National Cancer Institute diversity set, a library of 1990 compounds with nonredundant pharmacophore profiles, using AutoDock against AChBPs revealed 51 potential candidates. In vitro radioligand competition assays using [3H] epibatidine against the AChBPs from the freshwater snails, Lymnaea stagnalis, and from the marine species, Aplysia californica and the mutant (AcY55W), revealed seven compounds from the list of candidates that had micromolar to nanomolar affinities for the AChBPs. Further investigation on α7nAChR expressing in Xenopus oocytes and on the recombinant receptors with fluorescence resonance energy transfer (FRET)-based calcium sensor expressing in HEK cells showed that seven compounds were antagonists of α7nAChR, only one compound (NSC34352) demonstrated partial agonistic effect at low dose (10 μM), and two compounds (NSC36369 and NSC34352) were selective antagonists on α7nAchR with moderate potency. These hits serve as novel templates/scaffolds for development of more potent and specific in the AChR systems. © 2012 Society for Laboratory Automation and Screening.